Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Single Center, Randomized, Placebo-controlled, Double-blind, Parallel Group Study to Evaluate Efficacy of Para-Tyrosine Supplementation on the Survival and Clinical Outcome in Patients With Sepsis

NCT03278730 is registered in ClinicalTrials.gov with University of Pecs as lead sponsor.

NCT NCT03278730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03278730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Single Center, Randomized, Placebo-controlled, Double-blind, Parallel Group Study to Evaluate Efficacy of Para-Tyrosine Supplementation on the Survival and Clinical Outcome in Patients With Sepsis
Lead sponsor
University of Pecs
Phase
Phase 2
Overall status
Suspended
Start date
January 31, 2027
Completion date
February 28, 2027
Enrollment
296 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis